A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

Published:2007-07 Issue:4 Volume:17 Page:771-776
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

MICHA J.P.,GOLDSTEIN B.H.,RETTENMAIER M.A.,GENESEN M.,GRAHAM C.,BADER K.,LOPEZ K.L.,NICKLE M.,BROWN J.V.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference33 articles.

1. Cancer Statistics, 2001

2. Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma

3. Investigating the Potential of Bevacizumab in Other Indications: Metastatic Renal Cell, Non-Small Cell Lung, Pancreatic and Breast Cancer

4. Tumor Angiogenesis and Molecular Target Therapy in Ovarian Carcinomas

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing a Pathomics Biomarker to Predict the Effectiveness of Bevacizumab in Ovarian Cancer Treatment;Bioengineering;2024-07-03

2. Targeted Molecular Therapy for Ovarian Cancer Patients;Advances in Diagnosis and Management of Ovarian Cancer;2022

3. Principles of radiation therapy and chemotherapy in gynecologic cancer;Comprehensive Gynecology;2022

4. Personalized Medicine in Ovarian Cancer: A Perspective From Mexico;World Journal of Oncology;2021-08

5. Chemotherapy Resistance in Advanced Ovarian Cancer Patients;Biomarkers in Cancer;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP